Skip to main content

Closed

SPRC: SciSparc Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-34.5% / yr

Operating margin-1022.1%

ROIC-152.6%

Financially safe

Stretched

Debt / equity0.09×

Interest coverage-1.1×

Current ratio2.41×

SciSparc Ltd.

SPRCNASDAQ Capital Market·USD·Closed

SciSparc Ltd.

SPRCNASDAQ·USD·Closed

$7.12

−18.16%

$7.12

−$1.58 (18.16%)

52W Range

5thpctl

Volume

0.12×avg

Mkt Cap

411814USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.12×avg

Market Cap

411814USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings